Discontinued — last reported Q4 '25
Johnson & Johnson EPS (Basic) decreased by 7.0% to $2.14 in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 91.1%, from $1.12 to $2.14. Over 3 years (FY 2021 to FY 2024), EPS (Basic) shows relatively stable performance with a -1.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher values indicate more value is being generated for each individual share held.
The portion of a company's profit allocated to each outstanding share of common stock, calculated using the actual numbe...
This is a standard benchmark used to compare the earnings power of companies regardless of their total size or market capitalization.
is_eps_basic| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.35 | $2.38 | $1.39 | $1.34 | $1.96 | $1.83 | $1.70 | $10.25 | -$0.03 | $1.98 | $1.68 | $1.35 | $1.95 | $1.12 | $1.42 | $4.57 | $2.30 | $2.14 |
| QoQ Change | — | +1.3% | -41.6% | -3.6% | +46.3% | -6.6% | -7.1% | +502.9% | -100.3% | >999% | -15.2% | -19.6% | +44.4% | -42.6% | +26.8% | +221.8% | -49.7% | -7.0% |
| YoY Change | — | — | — | — | -16.6% | -23.1% | +22.3% | +664.9% | -101.5% | +8.2% | -1.2% | -86.8% | >999% | -43.4% | -15.5% | +238.5% | +17.9% | +91.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.